200P - Effects of delayed initiation of adjuvant trastuzumab for non-metastatic, HER2 positive breast cancer in a limited resources setting: ML25232 study final results
| Autor: | Beslija, S., Ceric, T., Hasanbegovic, B., Skenderi, F., Alidžanović, J., Kopric, D., Marjanović, I., Mekic-Abazovic, A., Sisic, I.S., Hammami, M., Pasic, A., Rasic, A., Kapisazović, E. |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v68-v68 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|